Lloyd Buffy, Groat Danielle, Cook Curtiss B, Kaufman David, Grando Adela
Arizona State University Department of Biomedical Informatics, AZ.
Stud Health Technol Inform. 2015;216:93-7.
Diabetes is a complex disease affecting 29.1 million (9.3%) US citizens [1]. It is a chronic illness that needs continual medical care and ongoing patient self-management, education, and support [2]. There is no cure for diabetes, requiring patients to conduct frequent self-monitoring of blood glucose and dosing of insulin in many cases. Evidence has shown that patients are more adherent to their diabetes management plan when they incorporate personal lifestyle choices [3]. To address the challenge of empowering patients to better manage their diabetes, we have developed a novel mobile application prototype, iDECIDE, that refines rapid-acting insulin dose calculations by incorporating two important patient variables in addition to carbohydrates consumed that are not a part of standard insulin dose calculation algorithms: exercise and alcohol intake [4, 5]. A retrospective analysis for the calibration and evaluation of iDECIDE is underway by comparing recommendations made by the application against dosing recommendations made by insulin pumps.
糖尿病是一种复杂的疾病，影响着2910万（9.3%）美国公民[1]。它是一种慢性病，需要持续的医疗护理以及患者持续的自我管理、教育和支持[2]。糖尿病无法治愈，在许多情况下，患者需要频繁进行血糖自我监测并注射胰岛素。有证据表明，当患者将个人生活方式选择纳入其中时，他们会更严格地遵守糖尿病管理计划[3]。为应对帮助患者更好地管理糖尿病这一挑战，我们开发了一款新型移动应用程序原型iDECIDE，除了消耗的碳水化合物外，该应用程序还纳入了两个重要的患者变量（这两个变量并非标准胰岛素剂量计算算法的一部分）：运动和酒精摄入量，从而优化速效胰岛素剂量计算[4,5]。目前正在通过将该应用程序给出的建议与胰岛素泵给出的给药建议进行比较，对iDECIDE进行校准和评估的回顾性分析。
